Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Blood cancer treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Blood cancer treatmentmarket, defines the market attractiveness level of Blood cancer treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Blood cancer treatment industry, describes the types of Blood cancer treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Blood cancer treatment market and the development prospects and opportunities of Blood cancer treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Blood cancer treatment market in Chapter 13.
By Player:
Gilead Sciences
AstraZeneca
Takeda
AbbVie
Novartis
Amgen
Johnson & Johnson
Pfizer
Roche
By Type:
chemotherapy
immunotherapy
Targeted therapy
other
By End-User:
lymphoma
other
Multiple myeloma
leukemia
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Blood cancer treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Blood cancer treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Blood cancer treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Blood cancer treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Blood cancer treatment Market Analysis and Outlook to 2022
-
7.1 Global Blood cancer treatment Consumption (2017-2022)
-
7.2 United States Blood cancer treatment Consumption (2017-2022)
-
7.3 Europe Blood cancer treatment Consumption (2017-2022)
-
7.4 China Blood cancer treatment Consumption (2017-2022)
-
7.5 Japan Blood cancer treatment Consumption (2017-2022)
-
7.6 India Blood cancer treatment Consumption (2017-2022)
-
7.7 South Korea Blood cancer treatment Consumption (2017-2022)
8 Region and Country-wise Blood cancer treatment Market Analysis and Outlook to 2028
-
8.1 Global Blood cancer treatment Consumption Forecast (2022-2028)
-
8.2 United States Blood cancer treatment Consumption Forecast (2022-2028)
-
8.3 Europe Blood cancer treatment Consumption Forecast (2022-2028)
-
8.4 China Blood cancer treatment Consumption Forecast (2022-2028)
-
8.5 Japan Blood cancer treatment Consumption Forecast (2022-2028)
-
8.6 India Blood cancer treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Blood cancer treatment Consumption Forecast (2022-2028)
9 Global Blood cancer treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Blood cancer treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global immunotherapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Targeted therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global other Consumption and Growth Rate (2017-2022)
-
9.2 Global Blood cancer treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global other Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Multiple myeloma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global leukemia Consumption and Growth Rate (2017-2022)
10 Global Blood cancer treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Blood cancer treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Targeted therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Blood cancer treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global other Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Multiple myeloma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global leukemia Consumption Forecast and Growth Rate (2022-2028)
11 Global Blood cancer treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Blood cancer treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Blood cancer treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Blood cancer treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Blood cancer treatment Market Competitive Analysis
-
14.1 Gilead Sciences
-
14.1.1 Gilead Sciences Company Details
-
14.1.2 Gilead Sciences Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Sciences Blood cancer treatment Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Blood cancer treatment Product and Service
-
14.3 Takeda
-
14.3.1 Takeda Company Details
-
14.3.2 Takeda Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Takeda Blood cancer treatment Product and Service
-
14.4 AbbVie
-
14.4.1 AbbVie Company Details
-
14.4.2 AbbVie Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Blood cancer treatment Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Blood cancer treatment Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Blood cancer treatment Product and Service
-
14.7 Johnson & Johnson
-
14.7.1 Johnson & Johnson Company Details
-
14.7.2 Johnson & Johnson Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Johnson & Johnson Blood cancer treatment Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Blood cancer treatment Product and Service
-
14.9 Roche
-
14.9.1 Roche Company Details
-
14.9.2 Roche Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Roche Blood cancer treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Blood cancer treatment
-
Figure Blood cancer treatment Picture
-
Table Global Blood cancer treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Blood cancer treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Blood cancer treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Blood cancer treatment Consumption by Country (2017-2022)
-
Figure United States Blood cancer treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Blood cancer treatment Consumption and Growth Rate (2017-2022)
-
Figure China Blood cancer treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Blood cancer treatment Consumption and Growth Rate (2017-2022)
-
Figure India Blood cancer treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Blood cancer treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Blood cancer treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Blood cancer treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Blood cancer treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Blood cancer treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Blood cancer treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Blood cancer treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Blood cancer treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted therapy Consumption and Growth Rate (2017-2022)
-
Figure Global other Consumption and Growth Rate (2017-2022)
-
Figure Global lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global other Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple myeloma Consumption and Growth Rate (2017-2022)
-
Figure Global leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Blood cancer treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Blood cancer treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Blood cancer treatment Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Blood cancer treatment Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Blood cancer treatment Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Blood cancer treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Blood cancer treatment Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Blood cancer treatment Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Blood cancer treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Blood cancer treatment Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Blood cancer treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Blood cancer treatment Product and Service
-
